These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2343820)

  • 41. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
    Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
    Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of ventricular tachycardia inducibility in programmed electrical stimulation and the effectiveness of serial drug testing: Polish multicenter study.
    Wnuk-Wojnar AM; Giec L; Drzewiecki J; Trusz-Gluza M; Dabrowski A; Pasyk S
    Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2127-32. PubMed ID: 1704606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
    Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
    Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
    Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
    Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS; Marchlinski FE; Buxton AE; Doherty JU; Waxman HL; Josephson ME
    Circulation; 1984 Sep; 70(3):451-6. PubMed ID: 6744550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
    Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
    J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug response at electropharmacologic study in patients with ventricular tachyarrhythmias: the importance of ventricular refractoriness.
    Gillis AM; Wyse DG; Duff HJ; Mitchell LB
    J Am Coll Cardiol; 1991 Mar; 17(4):914-20. PubMed ID: 1999629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents.
    Constantin L; Martins JB; Kienzle MG; Brownstein SL; McCue ML; Hopson RC
    Pacing Clin Electrophysiol; 1989 May; 12(5):776-83. PubMed ID: 2471163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
    Denniss AR; Ross DL; Richards DA; Cody DV; Russell PA; Young AA; Uther JB
    Am J Cardiol; 1986 Aug; 58(3):261-5. PubMed ID: 3739914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early assessment of the effect of map-guided transcatheter intracardiac electric shock on sustained ventricular tachycardia secondary to coronary artery disease.
    Garan H; Kuchar D; Freeman C; Finkelstein D; Ruskin JN
    Am J Cardiol; 1988 May; 61(13):1018-23. PubMed ID: 3284317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical efficacy and electrophysiology of imipramine for ventricular tachycardia.
    Connolly SJ; Mitchell LB; Swerdlow CD; Mason JW; Winkle RA
    Am J Cardiol; 1984 Feb; 53(4):516-21. PubMed ID: 6695781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Day-to-day reproducibility of antiarrhythmic drug trials using programmed extrastimulus techniques for ventricular tachyarrhythmias associated with coronary artery disease.
    Kudenchuk PJ; Kron J; Walance CG; Cutler JE; Griffith KK; McAnulty JH
    Am J Cardiol; 1990 Sep; 66(7):725-30. PubMed ID: 2399890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J; Haines DE; Lerman BB; DiMarco JP
    Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapy for late post infarction ventricular tachycardia.
    Somberg JC; Butler B; Torres V; Tepper D; Keren G; Siegel L; Jentzer J; Miura DS
    Angiology; 1985 Mar; 36(3):181-90. PubMed ID: 3896040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ; Britchkow D; Marinchak RA; Kowey PR
    Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
    Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
    Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.